News brief
On 2026-03-19, according to Xiniu Data, iRegene completed equity financing for an undisclosed amount. Investors were Xiangfeng Investment.
Connected profiles
Explore
Sources · 0Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
No source links are available for this profile.
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
2026年3月19日，据烯牛数据报道，睿健医药完成股权投资融资，金额未披露。投资方为祥峰投资。